Biotech Stocks Survive The Sector Rotation

One of the hardest parts of the last quarter has been the sector rotation. Sector rotation itself isn’t a bad thing but when combined with choppiness it can wreak havoc on a portfolio. However, the biotech stocks seem to not only be surviving, but thriving, too. It can be a hard industry to profit from with so many clinical trials,…